In a recent study, researchers identified advanced skin fibrosis at baseline as a predictor of likely regression — or disease improvement — in patients under standard of…
Articles by Patricia Inácio, PhD
Researchers recently discovered a natural molecule, the M10 peptide, that can significantly decrease fibrosis in a mouse model of scleroderma. The study, “…
Therapeutics targeting microRNA showed signs of success in mouse models of scleroderma — particularly in skin lesions with topical applications…
A new technique called nailfold videocapillaroscopy (NVC) is a potential way of identifying systemic sclerosis patients at risk of disease progression and severity,…
A research team recently proposed that injecting fat and stromal vascular fraction in the face and hands of systemic sclerosis…
A team of researchers at Laura and Isaac Perlmutter Cancer Center developed an antiscarring paste that prevents the progression…
In a new study entitled “Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in…
In a recent study entitled “B regulatory cells are decreased and functionally impaired in patients with systemic…
In a recent study entitled “Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease”, researchers present a case-report…
According to a study recently presented at the Annual European Congress of Rheumatology (EULAR), Rome, patients with systemic sclerosis harbor…